Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 437871, 6 pages
http://dx.doi.org/10.1155/2014/437871
Research Article

Development of Pathological Diagnostics of Human Kidney Cancer by Multiple Staining Using New Fluorescent Fluolid Dyes

1Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan
2Department of Nanoscience, Faculty of Engineering, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan
3Department of Applied Chemistry and Biochemistry, Faculty of Engineering, Kyushu Sangyo University, 2-3-1 Matsukadai, Higashi-ku, Fukuoka 813-8503, Japan
4Ibaraki Medical Center, Tokyo Medical University, 3-20-1 Ami, Inashiki, Ibaraki 300-0395, Japan

Received 16 February 2014; Accepted 20 May 2014; Published 3 June 2014

Academic Editor: Paul Crispen

Copyright © 2014 Dilibaier Wuxiuer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. W. Hedley, M. Pintilie, J. Woo et al., “Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis,” The American Journal of Pathology, vol. 164, no. 2, pp. 557–565, 2004. View at Google Scholar · View at Scopus
  2. M. Balic, H. Lin, L. Young et al., “Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype,” Clinical Cancer Research, vol. 12, no. 19, pp. 5615–5621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Snyder, D. Bailey, M. Shipitsin, K. Polyak, and M. Loda, “Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies,” Laboratory Investigation, vol. 89, no. 8, pp. 857–866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Kai, H. Onishi, M. Souzaki et al., “Semi-quantitative evaluation of CD44(+)/CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method,” Cancer Science, vol. 102, no. 12, pp. 2132–2138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Li, M. Guillaud, M. Follen, and C. MacAulay, “Double staining cytologic samples with quantitative feulgen-thionin and Anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cells,” Analytical and Quantitative Cytology and Histology, vol. 34, no. 5, pp. 273–284, 2012. View at Google Scholar · View at Scopus
  6. R. Kiyama, Y. Zhu, and T. Aoyagi, “Genetics of renal tumors,” in Renal Tumors, J. Chen, Ed., pp. 3–30, InTech, Rijeka, Croatia, 2013. View at Google Scholar
  7. Y. Zhu, T. Ogaeri, J.-I. Suzuki et al., “Application of fluolid-orange-labeled probes for DNA microarray and immunological assays,” Biotechnology Letters, vol. 33, no. 9, pp. 1759–1766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kanemaru, K. Hirata, S.-I. Takasu et al., “A fluorescence scanning electron microscope,” Ultramicroscopy, vol. 109, no. 4, pp. 344–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Matsuda, T. Matsuda, Japan Cancer Surveillance Research Group et al., “Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project,” Japanese Journal of Clinical Oncology, vol. 43, no. 3, pp. 328–336, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Rosner, G. Bratslavsky, P. A. Pinto, and W. M. Linehan, “The clinical implications of the genetics of renal cell carcinoma,” Urologic Oncology, vol. 27, no. 2, pp. 131–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. T. Cohen and F. J. McGovern, “Renal-cell carcinoma,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2477–2490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. R. Lane and M. W. Kattan, “Prognostic models and algorithms in renal cell carcinoma,” Urologic Clinics of North America, vol. 35, no. 4, pp. 613–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. S. Ng, C. G. Wood, P. M. Silverman, N. M. Tannir, P. Tamboli, and C. M. Sandler, “Renal cell carcinoma: diagnosis, staging, and surveillance,” The American Journal of Roentgenology, vol. 191, no. 4, pp. 1220–1232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. D. Stewart, F. C. O'Mahony, T. Powles, A. C. Riddick, D. J. Harrison, and D. Faratian, “What can molecular pathology contribute to the management of renal cell carcinoma?” Nature Reviews Urology, vol. 8, no. 5, pp. 255–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Kakinuma, Y. Zhu, Y. Wang, B. C. Roy, and R. Kiyama, “Kank proteins: structure, functions and diseases,” Cellular and Molecular Life Sciences, vol. 66, no. 16, pp. 2651–2659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Tickoo and A. Gopalan, “Pathologic features of renal cortical tumors,” Urologic Clinics of North America, vol. 35, no. 4, pp. 551–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. A. Al-Ahmadie, D. Alden, S. W. Fine et al., “Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study,” The American Journal of Surgical Pathology, vol. 35, no. 7, pp. 949–961, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. D. Truong and S. S. Shen, “Immunohistochemical diagnosis of renal neoplasms,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 1, pp. 92–109, 2011. View at Google Scholar · View at Scopus
  19. S. R. Shi, M. E. Key, and K. L. Kalra, “Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections,” Journal of Histochemistry and Cytochemistry, vol. 39, no. 6, pp. 741–748, 1991. View at Google Scholar · View at Scopus
  20. B. C. Roy, T. Aoyagi, S. Sarkar et al., “Pathological characterization of Kank in renal cell carcinoma,” Experimental and Molecular Pathology, vol. 78, no. 1, pp. 41–48, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Sato, T. Yoshizato, Y. Shiraishi et al., “Integrated molecular analysis of clear-cell renal cell carcinoma,” Nature Genetics, vol. 45, no. 8, pp. 860–867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. B. P. Adley, V. Papavero, J. Sugimura, B. T. Teh, and X. J. Yang, “Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma,” Analytical and Quantitative Cytology and Histology, vol. 28, no. 4, pp. 228–236, 2006. View at Google Scholar · View at Scopus
  23. J. K. Kim, S. Y. Park, J. H. Shon, and K. S. Cho, “Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT,” Radiology, vol. 230, no. 3, pp. 677–684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Xu, Q. Cao, N. Liu, Z. Fang, Z. Ye, and T. Peng, “Renal collecting duct carcinoma with extensive coagulative necrosis mimicking anemic infarct: report of a case and the literature review,” Diagnostic Pathology, vol. 8, no. 1, article 119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kuroda, A. Tanaka, C. Ohe, and Y. Nagashima, “Recent advances of immunohistochemistry for diagnosis of renal tumors,” Pathology International, vol. 63, no. 8, pp. 381–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Hohensee, F. G. La Rosa, P. Homer et al., “Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature,” Journal of Medical Case Reports, vol. 7, no. 1, article 118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ahn, G. Y. Kwon, Y. M. Cho et al., “Acquired cystic disease-associated renal cell carcinoma: further characterization of the morphologic and immunopathologic features,” Medical Molecular Morphology, vol. 46, no. 4, pp. 225–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Yasir, L. Herrera, C. Gomez-Fernandez et al., “CD10(+) and CK7/RON(-) immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers,” Applied Immunohistochemistry and Molecular Morphology, vol. 20, no. 5, pp. 454–461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. van der Loos, “Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 4, pp. 313–328, 2008. View at Publisher · View at Google Scholar · View at Scopus